Table 3. Characteristics of the patients in the responsive and unresponsive groups to sitagliptin therapy.
Responsive group | Unresponsive group | P | |
---|---|---|---|
n | 659 | 82 | |
Age (years) | 63.3 ± 11.4 | 64.4 ± 10.9 | NS |
Sex (male/female) | 381/278 | 43/39 | NS |
Duration of diabetes (years) | 10.9 ± 8.6 | 10.7 ± 7.5 | NS |
Baseline HbA1c (%) | 7.71 ± 1.16 | 7.10 ± 0.78 | <0.01 |
Baseline BMI (kg/m2) | 24.59 ± 4.25 | 25.52 ± 4.18 | <0.05 |
BMI, body mass index; HbA1c, glycated hemoglobin; NS, not significant.